Mehalick David
SEC insider (Form 3/4/5 filer). CIK 0001846623. CEO and President at Coeptis Therapeutics Holdings, Inc. (COEP). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 11, 2026. Located in WEXFORD, PA.
Companies Mehalick David has filed insider reports for
- Coeptis Therapeutics Holdings, Inc. (COEP): Director, Officer, 10% Owner, CEO and President
Mehalick David
CIK: 0001846623
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (33.3%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
COEP
Coeptis Therapeutics Holdings, Inc.
DirectorOfficer10% Owner
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 11, 2026COEP
Coeptis Therapeutics Holdings, Inc.
ExerciseDirect148.9K shares at avg. $7.05$1.0M - Feb 11, 2026COEP
Coeptis Therapeutics Holdings, Inc.
AwardDirect51.3K shares- - Mar 4, 2025COEP
Coeptis Therapeutics Holdings, Inc.
AwardDirectNon-Qualified Stock Options (right to buy)
28.9K shares-
1-3 of 3 transactions